Use of the PEAK PlasmaBlade 4.0 in Bilateral Breast Reduction

Withdrawn before enrolling · Not applicable

Conditions studied: Macromastia (Symptomatic)

In brief

The objective of this clinical study is to evaluate the operative performance of the PEAK PlasmaBlade® 4.0 during bilateral breast reduction; to monitor and record post-operative pain, adverse events and skin scarring following surgery; and to compare these outcomes to the HARMONIC SYNERGY® BLADE.

Key facts

Study ID
NCT01404351
Run by
Medtronic Surgical Technologies
People needed
0
Starts
2011-05-01
Expected to finish
2011-11-01
Last updated by the study team
2013-01-07

Who can join

Age: 18 and older, up to 70. Sex: female. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.